BDBM387150 2-[(3aR, 7aR)-6-{[2-(2,2- difluoroethoxy)phenyl]carbonyl}octahydro- 1H-pyrrolo[2,3-c]pyridin-1-yl]pyridine-4- carbonitrile::US9938276, E10

SMILES FC(F)COc1ccccc1C(=O)N1CC[C@H]2CCN([C@H]2C1)c1cc(ccn1)C#N

InChI Key InChIKey=DNUFHUXBYMRWHU-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 387150   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387150(2-[(3aR, 7aR)-6-{[2-(2,2- difluoroethoxy)phenyl]ca...)
Affinity DataIC50: 139nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM387150(2-[(3aR, 7aR)-6-{[2-(2,2- difluoroethoxy)phenyl]ca...)
Affinity DataIC50: 1.00E+4nMAssay Description:The utility of the compounds in accordance with the present invention as orexin receptor OX1R and/or OX2R antagonists may be readily determined witho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
US Patent